Dysregulated insulin signaling in the hypothalamus results in impaired metabolic control of liver and adipose tissue, while disrupted glucose transporters in the hippocampus lead to reduced neuronal plasticity, impaired cognition, and the development of depression. This evidence concerns the gene INS and depressive symptom measurement.